The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms.

S Parkkila, A Innocenti, H Kallio, M Hilvo, A Scozzafava, CT Supuran

Research output: Contribution to journal › Article › Scientific › peer-review

67 Citations (Scopus)

Access to Document

@article{e94f8a90a1f74744ae858ae6331d53e3,

title = "The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms.",

author = "S Parkkila and A Innocenti and H Kallio and M Hilvo and A Scozzafava and CT Supuran",

year = "2009",

doi = "10.1016/j.bmcl.2009.06.002",

language = "English",

volume = "19",

pages = "4102--4106",

number = "15",

}

TY - JOUR

T1 - The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms.

AU - Parkkila, S

AU - Innocenti, A

AU - Kallio, H

AU - Hilvo, M

AU - Scozzafava, A

AU - Supuran, CT

PY - 2009

Y1 - 2009

U2 - 10.1016/j.bmcl.2009.06.002

DO - 10.1016/j.bmcl.2009.06.002

M3 - Article

SN - 0960-894X

VL - 19

SP - 4102

EP - 4106

JO - Bioorg Med Chem Lett

JF - Bioorg Med Chem Lett

IS - 15

ER -